Method of treatment for muscular dystrophy

Details Method of treatment for muscular dystrophy Method of treatment for muscular dystrophy

1993-08-24

1995-07-18

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514907, A61K 31715

Patent

active

054341426

ABSTRACT:
Administering to a patient of muscular dystrophy a pharmaceutical agent containing glycyrrhizin and/or a pharmaceutically acceptable salt thereof as effective components is effective against muscular dystrophy, particularly, Duchenne or Becker muscular dystrophy and is highly safe with less side effect.

REFERENCES:
Dialog Information Services; File 155:Medline 1966-94; Accession No. 08087022; Abstract; and Eur. Neurol.; vol. 32, No. 1, 1992, pp. 44-51; S. Shintani et al; "Glycyrrhizin (licorice)-induced hypokalemic myopathy".
Bertorini, Tulio et al.; Muscle & Nerve; Jun. 1991; pp. 503-507; "Effect of Dantrolene in Duchenne Muscular Dystrophy".
Mendell, J. R., et al.; The New England Journal of Medicine; vol. 320, No. 24; Jun. 15, 1989; pp. 1592-1597; "Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy".
Lewis and Elvin-Lewis Medical Botany Plants Affecting Man's Health, John Wiley and Sons Publisher (N.Y.), pp. 215, 275, 1977.
Merck Manual, pp. 1392-1393, 1982.

Affiliated with

Also associated with

Rating

Method of treatment for muscular dystrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment for muscular dystrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for muscular dystrophy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2419044